More info:

• armod

  The product in question is a wakefulness-promoting agent containing armodafinil as the active pharmaceutical ingredient. It represents the R-enantiomer of modafinil, developed to address excessive daytime sleepiness associated with various sleep disorders. Unlike many traditional stimulants, it demonstrates a unique mechanism of action with lower abuse potential, making it particularly valuable in sleep medicine and situations requiring sustained alertness. Armodafinil: Enhanced Wakefulness for Sleep Disorders - Evidence-Based Review 1. Introduction: What is Armodafinil?

• artvigil

  Artvigil is a pharmaceutical-grade formulation of armodafinil, the R-enantiomer of modafinil, primarily indicated for improving wakefulness in patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder. Unlike many over-the-counter supplements, it’s a prescription medication that directly targets central nervous system histamine pathways. We initially viewed it as just another wakefulness agent, but its unique enantiopure properties created some fascinating clinical dilemmas. Artvigil: Enhanced Wakefulness and Cognitive Support for Sleep Disorders - Evidence-Based Review 1.

• modafresh

  Product Description: Modafresh represents the third-generation evolution in the wakefulness-promoting agent category, specifically engineered to address the pharmacokinetic limitations observed in earlier modafinil formulations. What distinguishes this preparation isn’t just the active pharmaceutical ingredient—armodafinil—but the proprietary delivery system that maintains consistent plasma concentrations across the dosing interval. We’ve moved beyond simple enantiomer separation to create a formulation that actually works predictably in clinical practice, not just in controlled trial conditions.

• modaheal

  Modaheal is a prescription-only medical device designed for transdermal delivery of modafinil, representing a significant advancement in wakefulness-promoting therapy. Unlike traditional oral formulations, this dermal patch system bypasses first-pass metabolism and provides sustained release over 16 hours, addressing several limitations of conventional treatment approaches for sleep disorders. The device consists of a multilayer polymer matrix containing micronized modafinil particles in a proprietary permeation-enhancing gel, which we’ve found particularly valuable for patients with gastrointestinal sensitivities or those requiring stable plasma concentrations throughout their waking hours.

• modalert

  Product Description: Modafinil, marketed under the brand name Modalert among others, is a wakefulness-promoting agent structurally distinct from amphetamines. It’s classified as a eugeroic (from Greek “good arousal”) and has become a cornerstone in managing excessive daytime sleepiness associated with narcolepsy, shift work sleep disorder, and obstructive sleep apnea/hypopnea syndrome. The tablets typically contain 100mg or 200mg of the active pharmaceutical ingredient modafinil. Unlike traditional stimulants that work broadly on catecholamine systems, modafinil’s mechanism is more selective, primarily targeting hypothalamic pathways to promote wakefulness without the significant peripheral side effects or high abuse potential.

• Modvigil: Enhanced Wakefulness and Cognitive Support - Evidence-Based Review

  Modvigil is a pharmaceutical-grade preparation of modafinil, a wakefulness-promoting agent classified as a eugeroic. It’s primarily indicated for managing excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder. Unlike traditional stimulants, modafinil demonstrates a unique neurochemical profile with lower abuse potential, making it a valuable tool in sleep medicine and off-label cognitive enhancement contexts. The tablets typically contain 100mg or 200mg of the active pharmaceutical ingredient modafinil, manufactured to comply with pharmacopeial standards for purity and dissolution.

• provigil

  Provigil, known generically as modafinil, is a wakefulness-promoting agent structurally distinct from traditional stimulants like amphetamines. Initially developed in France during the late 1970s and approved by the FDA in 1998, it’s classified as a Schedule IV controlled substance in the U.S. due to its potential for dependence, though significantly lower than older stimulants. Its primary mechanism involves selective action on dopamine, norepinephrine, and orexin/hypocretin systems rather than widespread monoamine release.

• Vilafinil: Enhanced Wakefulness and Cognitive Support - Evidence-Based Review

  Vilafinil represents one of those interesting cases where a pharmaceutical-grade cognitive enhancer crosses into the dietary supplement space, creating both opportunities and significant clinical dilemmas. It’s essentially a purified enantiomer of modafinil, but without the FDA pharmaceutical designation, it occupies this gray zone where patients are self-medicating for off-label cognitive benefits. The core appeal is its wakefulness-promoting and executive function enhancement, but the evidence landscape is…complicated, to say the least.

• waklert

  Waklert represents one of the more interesting developments in our armamentarium for managing excessive daytime sleepiness, particularly in narcolepsy and shift work sleep disorder. As a non-amphetamine wakefulness-promoting agent, it occupies a unique pharmacological niche that many clinicians are still getting comfortable with. The active pharmaceutical ingredient is armodafinil, which is the R-enantiomer of modafinil, and this distinction turns out to be clinically meaningful in ways we initially underestimated. Key Components and Bioavailability of Waklert The core of Waklert’s formulation is armodafinil, provided in tablets of 50mg, 150mg, and 250mg strengths.